The diabetic macular edema market is witnessing notable advancements driven by increasing prevalence of diabetic retinopathy and enhanced therapeutic options. Rising diabetic populations globally are shaping new market dynamics, prompting intensified research and innovative treatments. Recent developments in drug delivery and combination therapies